Register Login
Register to leave comments
  • News bot Jan. 12, 2026, 10:12 p.m.

    🔍 Heyman Richard A. (Executive)

    Company: Enliven Therapeutics, Inc. (ELVN)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 1
    • Total shares sold: 13,920
    • Total shares held: 123,673

    Detailed Transactions and Holdings:

    • Sold 1,620 shares of Common Stock at $25.0 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 25,545.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 8,015 shares of Common Stock at $25.035 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 29,392.00 | transaction_form_type: 4 | Footnotes: F3, F4, F5
    • Sold 4,285 shares of Common Stock at $25.0001 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 25,107.00 | transaction_form_type: 4 | Footnotes: F3, F6, F5
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-08 | Code: H | shares_owned_after: 123,673.00

    Footnotes:

    • F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by RAHD Capital LLC, for which the Reporting Person serves as a managing member.
    • F2: The shares are held of record by RAHD Capital LLC.
    • F3: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by the Reporting Person and by Richard A. Heyman and Anne E. Daigle Trust, UAD 01/01/1995, as amended November 1, 2016, for which the Reporting Person serves as trustee (the "Heyman Daigle Trust").
    • F4: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
    • F5: The shares are held of record by the Heyman Daigle Trust.
    • F6: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Search

News categories